Commerzbank Aktiengesellschaft FI Has $4.24 Million Position in MetLife, Inc. (NYSE:MET)

Commerzbank Aktiengesellschaft FI trimmed its position in MetLife, Inc. (NYSE:MET - Free Report) by 12.1% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 51,360 shares of the financial services provider's stock after selling 7,097 shares during the quarter. Commerzbank Aktiengesellschaft FI's holdings in MetLife were worth $4,237,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently modified their holdings of the company. Wolff Wiese Magana LLC grew its position in MetLife by 374.3% during the third quarter. Wolff Wiese Magana LLC now owns 351 shares of the financial services provider's stock worth $29,000 after buying an additional 277 shares in the last quarter. GoalVest Advisory LLC grew its holdings in shares of MetLife by 73.3% during the 1st quarter. GoalVest Advisory LLC now owns 390 shares of the financial services provider's stock worth $29,000 after purchasing an additional 165 shares in the last quarter. Bank & Trust Co bought a new position in shares of MetLife in the second quarter worth $39,000. Crewe Advisors LLC raised its stake in MetLife by 602.5% in the second quarter. Crewe Advisors LLC now owns 562 shares of the financial services provider's stock valued at $39,000 after purchasing an additional 482 shares in the last quarter. Finally, Larson Financial Group LLC lifted its position in MetLife by 72.6% during the second quarter. Larson Financial Group LLC now owns 568 shares of the financial services provider's stock worth $40,000 after purchasing an additional 239 shares during the period. Institutional investors and hedge funds own 89.81% of the company's stock.

MetLife Stock Performance

NYSE MET opened at $84.24 on Wednesday. The company has a market capitalization of $59.91 billion, a price-to-earnings ratio of 29.13, a PEG ratio of 0.69 and a beta of 1.04. MetLife, Inc. has a twelve month low of $57.91 and a twelve month high of $86.94. The stock has a fifty day simple moving average of $79.11 and a 200 day simple moving average of $74.29. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.56.

MetLife (NYSE:MET - Get Free Report) last issued its quarterly earnings data on Wednesday, July 31st. The financial services provider reported $2.28 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.13 by $0.15. MetLife had a return on equity of 21.41% and a net margin of 4.23%. The company had revenue of $17.82 billion during the quarter, compared to the consensus estimate of $18.57 billion. During the same period last year, the company earned $1.94 earnings per share. The firm's revenue was up 7.2% compared to the same quarter last year. Sell-side analysts expect that MetLife, Inc. will post 8.61 EPS for the current year.

MetLife Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, December 16th. Stockholders of record on Tuesday, November 5th will be paid a $0.545 dividend. This represents a $2.18 dividend on an annualized basis and a dividend yield of 2.59%. The ex-dividend date is Tuesday, November 5th. MetLife's dividend payout ratio is currently 74.91%.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on MET shares. Piper Sandler boosted their target price on shares of MetLife from $85.00 to $92.00 and gave the company an "overweight" rating in a research report on Wednesday, October 2nd. Bank of America cut their target price on MetLife from $99.00 to $96.00 and set a "buy" rating for the company in a research note on Thursday, August 1st. Keefe, Bruyette & Woods lowered their price target on MetLife from $86.00 to $85.00 and set an "outperform" rating for the company in a report on Monday, July 8th. StockNews.com downgraded MetLife from a "buy" rating to a "hold" rating in a research note on Friday, October 4th. Finally, Barclays began coverage on shares of MetLife in a report on Wednesday, September 4th. They issued an "overweight" rating and a $91.00 target price for the company. One research analyst has rated the stock with a hold rating and thirteen have issued a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $88.46.

MetLife Company Profile

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.